You must have a lot of "strikes" then, because just about ever company with a competing oncology drug says something to this effect when looking at preclinical data.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.